Pracinostat dihydrochloride

Overview

Pracinostat dihydrochloride is a potent histone deacetylase ( HDAC ) inhibitor, with IC 50 s of 40-140 nM, used for cancer research. Pracinostat dihydrochloride also inhibits metallo-β-lactamase domain-containing protein 2 ( MBLAC2 ) hydrolase activity with an EC 50 below 10 nM.

Application

Products | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Beta-lactamase | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-105246
• CAS No.: 929016-98-8
• Molecular Formula: C20H32Cl2N4O2
• Molecular Weight: 431.40
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source